Navigation Links
Identification of specific genes predicts which patients will respond to Hepatitis C treatment

hesis about what to look for," said Aled Edwards, a Professor in the Banting and Best Department of Medical Research at University of Toronto with cross appointments in the Departments of Medical Biophysics and Medical Genetics and Microbiology. He is also a senior scientist at the Clinical Genomics Centre at the University Health Network and Director and CEO of the Structural Genomics Consortium. "We cast a very wide net, looking at 19,000 genes of each of the patients."

The researchers found that the difference between those patients who did not respond to therapy to those who did was a subset of 18 genes. In the non-responders to treatment, 16 genes were turned on and two were turned off. Many of the 16 genes which were turned on are stimulated by interferon, one of the key antiviral agents that the body produces in response to viral infection and a medication that patients currently receive as part of their therapy. "Paradoxically, in the non-responders, the liver is revved up and the genes are responding like mad, but there is something about the response that just does not work," said Dr. McGilvray.

In the near future, determining the levels of a small subset of genes in patients' liver biopsies, with perhaps a simple blood test, may be helpful in deciding who will respond to treatment of chronic Hepatitis C with the current combination therapy using the synthetic antiviral agent ribavirin and interferon. This treatment can currently get rid of the virus in only roughly 50% of persons infected with genotype 1, the most common genotype in North America and world-wide.


'"/>

Source:University of Toronto


Page: 1 2 3

Related biology news :

1. Products containing specific probes for detecting alternative splice forms protected
2. Scientists generate patient-specific stem cells, Science study says
3. Eating, body weight regulated by specific neurons
4. Tool developed to silence genes in specific tissues using RNAi
5. Gene-specific Ebola therapies protect non-human primates from lethal disease
6. Unique dual target specificity of kinase inhibitor key for success against cancer
7. Serotonin, acting in a specific brain region, promotes sleep in fruit flies
8. A new male-specific gene in algae unveils an origin of male and female
9. Scientists identify specific enzymes that make meningitis hard to fight
10. Newly-discovered class of genes determines ?and restricts ?stem cell fate
11. Inexpensive, mass-produced genes core of synthetic biology advances at UH

Post Your Comments:
(Date:12/2/2009)...re reporting the first identification of substance...hat changes harmless marine bacteria into killers ...in ACS, Environmental Science & Technology , a se... note that bleaching already has destroyed up to 3...ts are searching for ways to slow or stop the dama...
(Date:12/2/2009)..., REDWOOD SHORES, Calif. and PALM HARBOR, Fla.,...telligence Corporation ("CIC") (OTC Bulletin Board...e solutions for business process automation in the...n biometric signature verification and Docubase Sy...lectronic Document Management (EDM) software provi...
(Date:12/2/2009)...d nanotubescylinders of carbon about a nanometer i...plications such as ultrastrong fibers, electrical ...mponents for fuel cells. Thanks to a new developme...ndards and Technology (NIST) and five partners, yo...ion and destruction of an aggressive form of breas...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2AMR Research Analyst Named One of the Most Inspiring Individuals in Life Sciences by PharmaVOICE 55863 1AMR Research Analyst Named One of the Most Inspiring Individuals in Life Sciences by PharmaVOICE 55863 2AMR Research Analyst Named One of the Most Inspiring Individuals in Life Sciences by PharmaVOICE 55863 3SIGVARIS USA Extends Educational Efforts in Healthy Advices Skin Care Network 55860 1SIGVARIS USA Extends Educational Efforts in Healthy Advices Skin Care Network 55860 2SIGVARIS USA Extends Educational Efforts in Healthy Advices Skin Care Network 55860 3Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 1Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 2
...eory into practice to manage complex and closely l...ts is a challenge, but one NOAA researcher Anne Gu...naging the value of our ocean resources. , Guerr...benefits that people obtain from ecosystems, in ma...cosystem Services Provided by the Nearshore in Pug...
...ease is available in French . , For more than a...iversity of Toronto to rev up the production of st...are adult blood stem cells and embryonic stem cell...s of them. Enough mouse heart cells that they form...ing engineering principles to stem cell research ...
...time frozen in place frozen solid All of these ph...et they all belie the truth about this southerly p...n ice and bears witness to some of the most extrem...ot static, and change here has always been dramati...sue of Ecology argues that the extreme cold and en...
Other Biology News:Can Dungeness crab and eelgrass help improve management of our marine resources? 2From stem cells to organs: The bioengineering challenge 2Antarctic life hung by a thread during ice ages 2Antarctic life hung by a thread during ice ages 3
(Date:12/2/2009)... , QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ ... (the "Company"), a global biopharmaceutical compa...y announced that the U.S. Food and Drug Administra...the Company,s PI3K/Akt pathway inhibitor compound,...sed/refractory multiple myeloma. Keryx Biopharmace...
(Date:12/1/2009)... , INCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-Fi...LI ) today announced revenue guidance for the four...y $57 million, as compared with $69 million for th...er 2008 results was the first of two installment p...ded in fourth quarter 2008 results was a one-time ...
(Date:12/1/2009)... , CAMBRIDGE, Mass., Dec. 1 /PRNewswire...logy industry and to promote its potential, a grou...tion of the Synthetic Biology Industry Association...he goal of the association is to provide a forum f... the new industry, address its opportunities and i...
(Date:12/1/2009)... , SAN FRANCISCO, Dec. 1 The B...lmost half the value it lost in October. The Selec...excellent month for the general markets with the D... value. The gains held firm in the final two tradi...t sluggish Thanksgiving holiday shopping and Dubai...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4
...needed to initiate therapy with Pfizer,s recently ...antagonist, MALIBU, Calif., Nov. 15 Pathway Diag... Office (USPTO) has issued U.S. Patent,number 7,29...1 Co-receptor,Use in the Clinical Care of HIV-1-In... the ,458 patent (with rights to sub-license) from...
...d 225.7% year-over-year to $2.3 million or 11 cent...AN CITY, Shandong, China, Nov. 15 /Xinhua-PRNewswi...nk Sheets: CBPO) ("CBP", "the Company"),one of the...the People,s,Republic of China ("PRC"), today repo...r ended on September 30, 2007. Third Quarter 2007...
...15 AlphaMed Press, publisher of the,journal STEM ...Stojkovic as,co-editors. Curt I. Civin, current S...recedented growth in areas of the journal,s most s... published, and number of manuscripts,submitted. D... assisted by,three outgoing senior editors: Alan M...
Other Biology Technology:Pathway Diagnostics Announces Patent Issuance for the Diagnostic Measurement of HIV Tropism for the Initiation or Modification of HIV Therapy 2China Biologic Products Reports Record Third Quarter 2007 Results 2China Biologic Products Reports Record Third Quarter 2007 Results 3China Biologic Products Reports Record Third Quarter 2007 Results 4China Biologic Products Reports Record Third Quarter 2007 Results 5China Biologic Products Reports Record Third Quarter 2007 Results 6China Biologic Products Reports Record Third Quarter 2007 Results 7China Biologic Products Reports Record Third Quarter 2007 Results 8China Biologic Products Reports Record Third Quarter 2007 Results 9China Biologic Products Reports Record Third Quarter 2007 Results 10STEM CELLS Journal Names Co-Editors 2
Mouse Anti-14-3-3 Binding Motif, phospho (Ser) Monoclonal Antibody, Unconjugated, Clone 4E2 from Cell Signaling Technology
Rat Anti-acetyl Salicylic Acid Polyclonal Antibody, Unconjugated from Abcam
Rat Anti-Acetyl Salicylic Acid conjugated Acetyl Salicylic Acid Polyclonal Antibody, Unconjugated from Cell Sciences
Rabbit Anti-UBC12 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: